Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) is a significant cause of morbidity and mortality worldwide.Current treatment options, even though potentially curative, have many limitations including a high rate of complications.Over the past few years immune checkpoint inhibitors (ICI) dish targeting cytotoxic lymphocyte antigen-4 (CTLA-4), program